Tacrolimus Extended-Release Capsules
3 NDCs across 1 manufacturer|0 Generic,3 Brand
▸ More about this market▾ Less
Tacrolimus Extended-Release Capsules is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $2.78 to $27.77 per EA — the most expensive product costs about 10.0× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$2.78 – $27.77
per EA
7d Activity
avg +0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing TACROLIMUS EXTENDED-RELEASE CAPSULES
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ASTAGRAF XL 5 MG CAPSULE | $27.7722 per EA | — |
ASTAGRAF XL 1 MG CAPSULE | $5.7091 per EA | — |
ASTAGRAF XL 0.5 MG CAPSULE | $2.7786 per EA | — |
Frequently Asked Questions
How many Tacrolimus Extended-Release Capsules products are on the market?
The Tacrolimus Extended-Release Capsules drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Tacrolimus Extended-Release Capsules?
NADAC reference prices for Tacrolimus Extended-Release Capsules range from $2.7786 to $27.7722 per EA — the most expensive product costs about 10.0× the cheapest.
Which manufacturers make Tacrolimus Extended-Release Capsules?
1 manufacturer lists Tacrolimus Extended-Release Capsules in NADAC. Ranked by number of NDCs, the largest are Astellas Pharma US, Inc. (3).